Simergent, a privately held company dedicated to advancing treatment for patients with kidney failure, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback